These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7308998)

  • 1. A peek at the Child-Turcotte classification.
    Conn HO
    Hepatology; 1981; 1(6):673-6. PubMed ID: 7308998
    [No Abstract]   [Full Text] [Related]  

  • 2. Systematic review: The model for end-stage liver disease--should it replace Child-Pugh's classification for assessing prognosis in cirrhosis?
    Cholongitas E; Papatheodoridis GV; Vangeli M; Terreni N; Patch D; Burroughs AK
    Aliment Pharmacol Ther; 2005 Dec; 22(11-12):1079-89. PubMed ID: 16305721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical and chemical course control of liver cirrhosis].
    Strohmeyer G; Dölle W; Martini GA
    Fortschr Med; 1973 Oct; 91(29):1140-4. PubMed ID: 4270664
    [No Abstract]   [Full Text] [Related]  

  • 4. Prognostic value of Pugh's modification of Child-Turcotte classification in patients with cirrhosis of the liver.
    Pasqualetti P; Di Lauro G; Festuccia V; Giandomenico G; Casale R
    Panminerva Med; 1992; 34(2):65-8. PubMed ID: 1408330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-fetoprotein serum concentration in different stages of liver cirrhosis.
    Wiercińska-Drapało A; Flisiak R; Prokopowicz D
    Rocz Akad Med Bialymst; 1997; 42(1):75-80. PubMed ID: 9581466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperprolactinemia in portosystemic encephalopathy.
    Sharma MP; Acharya SK; Karmarkar MG
    Indian J Med Res; 1987 Sep; 86():372-4. PubMed ID: 3428971
    [No Abstract]   [Full Text] [Related]  

  • 7. Assessment of liver cirrhosis severity in 1015 patients of the Euricterus database with Campbell-Child, Pugh-Child and with ascites and ascites-nutritional state (ANS) related classifications. Euricterus Project Management Group.
    Reisman Y; Gips CH; Lavelle SM
    Hepatogastroenterology; 1997; 44(17):1376-84. PubMed ID: 9356858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of Child-Turcotte criteria in medically treated cirrhosis.
    Christensen E; Schlichting P; Fauerholdt L; Gluud C; Andersen PK; Juhl E; Poulsen H; Tygstrup N
    Hepatology; 1984; 4(3):430-5. PubMed ID: 6724511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic coma in cirrhosis of the liver. The course and prognosis of 100 consecutive coma episodes.
    Prytz H; Sloth K
    Scand J Gastroenterol; 1973; 8(3):229-33. PubMed ID: 4724923
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prevention and therapy of complications of liver cirrhosis: ascites, encephalopathy and malnutrition].
    Köllinger M; Kullmann F; Holstege A; Schölmerich J
    Med Klin (Munich); 1996 Feb; 91(2):89-102. PubMed ID: 8850104
    [No Abstract]   [Full Text] [Related]  

  • 11. Liver function, age, and portasystemic encephalopathy.
    Kardel T
    Neth J Med; 1974; 17(2):50-3. PubMed ID: 4839374
    [No Abstract]   [Full Text] [Related]  

  • 12. Development and Performance of an Algorithm to Estimate the Child-Turcotte-Pugh Score From a National Electronic Healthcare Database.
    Kaplan DE; Dai F; Aytaman A; Baytarian M; Fox R; Hunt K; Knott A; Pedrosa M; Pocha C; Mehta R; Duggal M; Skanderson M; Valderrama A; Taddei TH;
    Clin Gastroenterol Hepatol; 2015 Dec; 13(13):2333-41.e1-6. PubMed ID: 26188137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cirrhosis and its complications].
    Pelletier G
    Rev Prat; 2005 May; 55(10):1135-41. PubMed ID: 16097260
    [No Abstract]   [Full Text] [Related]  

  • 14. Cirrhosis--treating the ascites and encephalopathy.
    Hardison WG
    Med Times; 1979 May; 107(5):23-30. PubMed ID: 449639
    [No Abstract]   [Full Text] [Related]  

  • 15. Prediction of mortality in cirrhosis of the liver.
    Lecompte Y; Metreau JM; Sancho HS; Bismuth H
    Surg Gynecol Obstet; 1974 Oct; 139(4):529-30. PubMed ID: 4608304
    [No Abstract]   [Full Text] [Related]  

  • 16. Risk factors for hepatic encephalopathy in patients with cirrhosis and refractory ascites: relevance of serum sodium concentration.
    Guevara M; Baccaro ME; Ríos J; Martín-Llahí M; Uriz J; Ruiz del Arbol L; Planas R; Monescillo A; Guarner C; Crespo J; Bañares R; Arroyo V; Ginès P
    Liver Int; 2010 Sep; 30(8):1137-42. PubMed ID: 20602681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival prediction in portacaval shunts: a computerized statistical analysis.
    Campbell DP; Parker DE; Anagnostopoulos CE
    Am J Surg; 1973 Dec; 126(6):748-51. PubMed ID: 4543312
    [No Abstract]   [Full Text] [Related]  

  • 18. The prognostic value of clinical and laboratory data in patients with cirrhosis.
    Winkel P; Juhl E; Tygstrup N
    Scand J Gastroenterol Suppl; 1970; 7():181-7. PubMed ID: 5271842
    [No Abstract]   [Full Text] [Related]  

  • 19. Prognostic significance of diabetes in patients with cirrhosis.
    Bianchi G; Marchesini G; Zoli M; Bugianesi E; Fabbri A; Pisi E
    Hepatology; 1994 Jul; 20(1 Pt 1):119-25. PubMed ID: 8020880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Independent prognostic factors in patients with liver cirrhosis.
    Piekarska A; Zboinska J; Szymczak W; Kuydowicz J
    Hepatogastroenterology; 2008; 55(84):1034-40. PubMed ID: 18705324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.